Plasma levels of soluble Urokinase Plasminogen Activator Receptor and Pepsinogen I/II ratios as gastric cancer biomarkers in Guatemalan patients
In Guatemala, gastric cancer (GC) presents some of the highest rates of incidence and mortality in the world.
Disparities in Gastric Cancer epidemiological profile in three Brazilian cities (Belem, Fortaleza and Sao Paulo)
Despite decreasing global incidence trends, gastric cancer is still among the five most incident cancers in the world and the third cancer-related cause of death.
Metabolite concentrations and H. pylori risk in GC cases and FDR controls
Serum pepsinogen 2 (sPG2) level is one of the predictive parameters for gastric cancer (GC) risk but factors that regulate change in PG2 expression are still unknown. Aim of the present study was to investigate genetic variants that may regulated PG2 expression in patients with GC or at risk for GC.
The profile of differentially expressed piRNAs associated to the field effect theory in gastric cancer
The knowledge about carcinogenesis and the molecular events that lead to cell transformation in gastric cancer (GC) has been a challenge to the scientific community. In this way, studies involving small non-coding RNAs have been widely explored.
Frequency of Helicobacter pylori in the population of Antioquia-Colombia and characterization of virulence genes CagA and VacA
Helicobacter pylori (Hp) is the main bacterial agent in gastroduodenal diseases.
Expression of oncogenic Delta-N p73 isoform is increased in Helicobacter pylori-infected individuals
Gastric carcinogenesis, in the form of intestinal-type gastric cancer (GC), consists of a series of sequential lesions known as Correa's multistep cascade of gastric cancer.